Introduction
============

As per the World Health Organization (WHO), the main cause of mortality worldwide is due to cardiovascular diseases (CVDs). According to the WHO report, in the year 2008 approximately 17.3 million people died due to CVDs, which is 30% of all global deaths and by 2030, the total number of deaths will increase up to 23.6 million, mainly from heart disease and stroke.[@b1-ppa-10-1259]

At present, the deaths occur due to lack of early medical diagnosis of CVDs, thereby posing a big challenge to health care organizations. Correct and timely diagnosis of patients is required for effective treatment and for quality service. The decisions are currently based on the experience and understanding of the doctor, instead of intelligent tools. To overcome this problem, the approach of combining clinical decision making supported by computer based patient records has been proposed by Wu et al.[@b2-ppa-10-1259] The main aim of the present approach was to minimize the possibilities of error in doctors' inference and decisions, which may also be safer for patients.[@b2-ppa-10-1259]

These days, some sort of information systems are being used by many hospitals to manage patients' information, but these systems are not used for clinical decision making. Many researchers have proposed CVD prediction systems based on different approaches. Khatibi and Montazer proposed a fuzzy-evidential based CVD prediction system in the year 2010, with which they have achieved accuracy of 91.58%.[@b3-ppa-10-1259] Akay proposed the neural network based coronary artery disease prediction system in 1992. They used 100 patient records for testing and achieved accuracy of 84% by using the data of clinical tests.[@b4-ppa-10-1259] The Bayesian classification and neural network based ischemic heart disease prediction system have been proposed by Kukar et al in 1999. They have used electrocardiogram (ECG) data as input for prediction.[@b5-ppa-10-1259] The probability theory (logistic regression) based angiographic coronary disease system has been proposed by Detrano et al in 1989. They have collected the data of 425 patients and achieved accuracy of 77%. The clinical and noninvasive test data have been used in the system for prediction.[@b6-ppa-10-1259]

To overcome the above gaps, an intelligent heart disease prediction system is proposed here, which uses the heart disease databases with quantum neural network (QNN) to make intelligent clinical decisions which cannot be done in traditional decision support systems.[@b7-ppa-10-1259] In this paper, the proposed system based on QNN has been compared with the Framingham risk score (FRS) using the same parameters as used in FRS.

Related work -- FRS
===================

The parameters used for FRS are sex, age, total cholesterol (TC), high density lipoprotein (HDL), systolic blood pressure, diastolic blood pressure, diabetes mellitus, body mass index (BMI), and smoking.[@b8-ppa-10-1259] The data of a group of patients were collected in the 1960s and 1970s and these data are used in the Framingham equations. Since then the cases of coronary heart disease (CHD) mortality have been decreasing.[@b9-ppa-10-1259] The lifestyle and other risk factors have been changed, which affected the rate of CHD. The FRS is outdated for the modern population. So the FRS is not accurate enough.

Common risk factors used in FRS and proposed system
===================================================

The details of common risk factors that are used in FRS and in the proposed system are as follows.

Sex
---

According to research, males are at greater risk of CVD than pre-menopausal females. Females after menopause are in the same risk category of CVD as males. On the other hand, the risk of stroke is equal for males and females.[@b10-ppa-10-1259]--[@b12-ppa-10-1259]

Age
---

The risk of CVD increases with the age. According to studies, after the age of 65 years, 80% of deaths occur due to heart disease. With the increase in age, our heart does not work properly.[@b10-ppa-10-1259]

TC
--

Elevated level of total blood cholesterol is one of the major causes of CVD.[@b13-ppa-10-1259] As blood cholesterol increases, the risk of CVD increases. [Table 1](#t1-ppa-10-1259){ref-type="table"} shows the various risk levels for TC.

HDL
---

Abnormality of HDL may increase the risk of atherosclerosis, risk levels are shown in [Table 2](#t2-ppa-10-1259){ref-type="table"}. According to research, the HDL level is a strong, independent inverse predictor of CVD.[@b14-ppa-10-1259]--[@b16-ppa-10-1259]

Blood pressure
--------------

It is the most important risk factor of heart diseases. Globally, various epidemiological studies have identified the direct relation between blood pressure elevation and rate of coronary artery disease and stroke.[@b17-ppa-10-1259]--[@b19-ppa-10-1259] It has also been identified that, the combined effect of multiple risk factors causes an increased risk.[@b20-ppa-10-1259] The normal blood pressure range according to age is shown in [Table 3](#t3-ppa-10-1259){ref-type="table"}.

Diabetes mellitus
-----------------

Diabetes is also one of the most important risk factors of heart diseases. It increases the risk of CVD. According to the Rancho Bernardo Study, diabetes increases the risk of CVD up to 1.9 times in males and 3.3 times in females.[@b21-ppa-10-1259] This study had been performed for 14 years on approximately 2,400 persons. The relation between diabetes and CVD is not uniform in all populations.[@b22-ppa-10-1259],[@b23-ppa-10-1259]

BMI
---

The BMI index is a statistical measurement. It shows the ratio between weight and height,[@b24-ppa-10-1259] as shown in [Table 4](#t4-ppa-10-1259){ref-type="table"}.

Smoking
-------

It is one of the most important factors which increase the risk of myocardial infarction (MI). Different research studies show that smoking/tobacco use increases the risk of MI.[@b25-ppa-10-1259] Proving the harmful effects of light smoking with adequate accuracy requires large cohort studies and only few studies have attempted this.[@b26-ppa-10-1259],[@b27-ppa-10-1259] According to studies, smoking is the main cause of 50% of deaths unrelated to CVD, which are avoidable and only one half of deaths happen due to CVD.[@b28-ppa-10-1259]--[@b31-ppa-10-1259]

Proposed CVD prediction system
==============================

The proposed system provides a comprehensive predictive tool for predicting the CVD risk. This system predicts CVD at an early stage. The clinicians, doctors, pathologists as well as general public may use this tool very easily. It predicts the chances of CVD using the physical tests for CVD. Using this tool, the clinicians may fulfill their promises and commitments for ensuring the sustained fight against this deadly disease. The activity diagram showing the structure of the proposed model is shown in [Figure 1](#f1-ppa-10-1259){ref-type="fig"}. The CHD forecast based on a study by Indrayan[@b32-ppa-10-1259] showed the number of cases, both male and female, of CHD in India ([Table 5](#t5-ppa-10-1259){ref-type="table"}). Here, in the proposed system for prediction, only the factors considered in the FRS have been considered here.

Materials and methods
=====================

The current study has been conducted during 2009 to 2015 on a cohort of CVD patients aged 20 years and above. During data collection, the personal details of patients were not collected. To build a knowledge based CVD prediction system, the QNN has been used in this approach for better adaptability and classification. This study has been conducted after the approval of Thapar University Research Board (TURB), who deemed that the patients' consent was not required for using retrospective/existing cohort without any identifiers linking to individuals.

Data description -- patients' data
----------------------------------

This study has been conducted with the data of 689 patients, showing the symptoms of CVD. The parameters of every individual patient have been diagnosed and analyzed by the three individual physicians. In [Table 6](#t6-ppa-10-1259){ref-type="table"}, the various input parameters are shown, which have been used for prediction of heart disease and used in the FRS. The FRS is designed for adults, ie, aged 20 years and above. The training and evaluation was performed with the help of a cardiologist/physician. The data consist of patients' records with doctors' predictions/diagnosis. The whole dataset is divided into training, validation, and testing. Furthermore, for validation purpose, the dataset of the famous Framingham study conducted on 5,209 CVD patients, was taken from the University of Washington, Seattle, WA, USA.[@b33-ppa-10-1259]

QNN used for CVD prediction system
----------------------------------

QNN based on multi-level transfer function was introduced by Karayiannis et al.[@b34-ppa-10-1259]--[@b36-ppa-10-1259] In comparison with artificial neural network, the hidden units of QNN use the nonlinear activation functions instead of linear, as used in artificial neural network. Here, the nonlinear activation function consists of linear superposition of multi-sigmoid function. In the recent past, various models of QNN have been used in other research areas such as, prediction of weather, disease diagnosis, voice recognition, and machine translation.[@b34-ppa-10-1259]--[@b38-ppa-10-1259] In such manner, more states can be expressed in a hidden layer neural cell in comparison to traditional sigmoid function in which only two states may be expressed.

Algorithm for training the QNN
------------------------------

The QNN with input, output, and hidden units are shown in [Figure 2](#f2-ppa-10-1259){ref-type="fig"}. Here, only one hidden layer has been used. Every node of hidden layer represents three sub-states in itself with the difference of quantum interval *θ^r^* with quantum level *r*. Let us assume that *n~s~* denotes the number of grades or excitation levels, *η* is learning rate which is a small random value, *δ~k~* is error rate of output layer, and *δ~j~* error rate of hidden layer; where *n~i~* denotes the input to the input layer; *O~j~* and *O~k~* denote the output of hidden and output layer, respectively. The weights between input and hidden layers are denoted by *W~ij~* and the weights between hidden and output layers are denoted by *W~kj~*.[@b37-ppa-10-1259]--[@b41-ppa-10-1259]

The initial weights are small random numbers and *t* denotes target value. Given R training pairs {*n*~1~, *t*~1~; *n*~2~, *t*~2~; *n*~R~, *t*~R~}; where *n~i~* (J × 1) is input and *t~i~* (K × 1) is target values for given inputs, as shown in [Figure 2](#f2-ppa-10-1259){ref-type="fig"}.

The error signal term of the output (*δ~k~*) and hidden layers (*δ~j~*) are written as, $$\delta_{k} = (t_{k} - O_{k})O_{k}(1 - O_{k})\quad\{ k = 1,2,3\ldots,K\}$$ $$\delta_{j} = O_{j}(1 - O_{j}){\sum\limits_{k}{W_{kj}^{New}\delta_{k}}}\{ j = 1,2,3\ldots,J\}\text{and}\{ k = 1,2,3\ldots,K\}$$

Consequently, output layer weights $(W_{kj}^{New})$ and hidden layer weights $(W_{ji}^{New})$ are adjusted as, $$W_{kj}^{New} = W_{kj}^{old} + \eta\delta_{k}O_{j}\{ j = 1,2,3\ldots,J\}\text{and}\{ k = 1,2,3\ldots,K\}$$ $$W_{ji}^{New} = W_{ji}^{old} + \eta\delta_{j}O_{i}\{ i = 1,2,3\ldots,I\}\text{and}\{ j = 1,2,3\ldots,J\}$$

The simple sigmoid function has been used as the activation function from input to hidden layer and is expressed as: $$sgm(x) = (1/(1 + \exp( - x)))$$

The sigmoid function with various graded levels has been used as the activation function for each hidden neuron, ie, from hidden to output layer is expressed as follows: $$sgm(x) = {\sum\limits_{r = 1}^{n_{s}}{(1/(1 + \exp( - x + \theta^{r})))}}$$

After *i* iterations, when minimum possible error is obtained, then increase quantum interval by very small quantum interval Δ*θ* $$\theta^{r} = \theta^{r} + \Delta\theta$$

The step by step details of the above discussed algorithm is expressed by in the flowchart shown in [Figure 3](#f3-ppa-10-1259){ref-type="fig"}.

Experiments and result
======================

During the training process of QNN, the best possible weights have been identified for each node of every layer by conducting the different experiments as shown in [Figure 3](#f3-ppa-10-1259){ref-type="fig"}. The whole dataset has been randomly divided and selected into training set, validation set, and test set as shown in [Table 7](#t7-ppa-10-1259){ref-type="table"}.

The architecture of the QNN consists of seven input nodes, 85 hidden nodes, and one output node as shown in [Figure 2](#f2-ppa-10-1259){ref-type="fig"}. The numbers of hidden nodes have been identified after several experiments. During our study, we have consulted several physicians and identified four groups of risk categories according to percentage level as "normal", "low risk range", "intermediate risk range", and "highest risk range". The percentage for each level is shown in [Table 8](#t8-ppa-10-1259){ref-type="table"}.

During training of the proposed system, we presumed the baseline values of all the risk parameters, these values are identified on the basis of our study and consulting physicians, as shown in [Table 9](#t9-ppa-10-1259){ref-type="table"}. The baseline value varies on the basis of "age and gender category".[@b42-ppa-10-1259] In our study, we presumed if the values lie up to baseline values, the patient should be treated as a healthy person without CVD.

To attain maximum performance, fine-tuning of the network architecture was performed. Particularly, number of nodes in the hidden layer was adjusted for QNN. In this study, we have only considered the risk factors used in FRS, significant for CVD. After analysis of patients' data, the patients may be categorized on the basis of reference range.

The collected patient information indicated that 63% of them were suffering from high blood pressure followed by 23% with normal blood pressure, and 8% with lower blood pressure. Twenty-seven percent of these patients exhibited increased HDL while 73% had low HDL. Similarly, 82% of the patients exhibited TC in higher range as exhibited in [Table 10](#t10-ppa-10-1259){ref-type="table"}.

Besides the earlier discussed parameters, 75.65% of patients were nonsmokers and 24.35% were smokers. An amount of 85.50% of patients were on medication and 14.50% were not taking any medication, as shown in [Table 11](#t11-ppa-10-1259){ref-type="table"}.

Out of 689 patients' data, the data of 250 CVD patients with the doctors' diagnoses (predictions) were collected for evaluation and validation purposes. The proposed system achieved 98.57% accuracy in predicting the level of CVD risk in patients. The result of our proposed system is significantly higher than the other existing approaches as shown in [Table 12](#t12-ppa-10-1259){ref-type="table"}.

It is evident that FRS is a commonly used method by doctors/practitioners worldwide for the prediction of CVDs. We carried out a comparison of our system with the FRS method. The same dataset was used for comparison of both the systems. The tool for FRS is available at <http://cvrisk.mvm.ed.ac.uk/calculator/calc.asp>.[@b43-ppa-10-1259] As discussed earlier, the FRS is outdated in the present scenario, and has many drawbacks as it underestimates the risk. This tool is not designed for a person below 20 years of age.

The proposed system based on QNN shows an average accuracy of 98.57% using the same data used for FRS accuracy prediction level, as shown in [Table 13](#t13-ppa-10-1259){ref-type="table"}. [Figure 4](#f4-ppa-10-1259){ref-type="fig"} shows the accuracy graph of the proposed system.

The proposed system has been tested and validated using the dataset of the famous Framingham study. The dataset of 5,209 CVD patients of the Framingham study has been taken from the University of Washington, Seattle, WA, USA (<http://courses.washington.edu/b513/datasets/datasets.php?class=513>).[@b33-ppa-10-1259] The test results also confirm the effectiveness of the proposed system, as shown in [Table 14](#t14-ppa-10-1259){ref-type="table"}.

In the Framingham study dataset, out of 5,209 patients, 378 deaths were recorded due to MI and 605 due to CHD. Out of the 378 deaths due to MI, 32.93% of patients had a very high risk prediction and 41.46% had an intermediate risk prediction, only 25.62% of patients had a low risk prediction. In case of deaths recorded due to CHD, out of 605 patients, 37.17% had a high risk prediction and 43.77% an intermediate risk prediction, while 19.06% were placed in the low risk category by the proposed system. In general, all the recorded cases of death were predicted to be at risk by the proposed system, out of which approximately 77% of deaths were predicted as very high risk category and only 23% were predicted as low risk. Here, in one of the most important causes for mortality, it must be taken into consideration that medication can affect mortality even though the patient is at low risk. The CVD risk predictions by the proposed system, using the dataset of the Framingham study, confirmed the potential risk of death, deaths which actually occurred and had been recorded as due to MI in the dataset of the Framingham study.

Discussion
==========

The FRS and European heart score are commonly used methods which are considered as most effective methods for CVD risk prediction. However, these methods have some major drawbacks such as being less accurate and based on a very old study conducted in the 1960s wherein the parameters taken into consideration were also limited. The validity of the Framingham equation is undetermined as the lifestyle of the population has changed completely. The newly available risk parameters are not included. On the other hand, these systems are based on conventional statistical methods and are not updated with time according to changed environmental and lifestyle conditions. Presently, the accuracy of the FRS is only 19.22%, as evaluated and compared with the proposed system using the same data. The major drawbacks of these studies are their ineffectiveness with regard to value ranges, ie, the FRS is only applicable for patients aged 20 to 100 years and the maximum threshold limit of CVD risk is 30%.

On the other hand in European heart score, if blood pressure is over 180 mmHg or cholesterol over 8 mmol/L, patients are automatically classified as high risk without considering the medication factor.[@b44-ppa-10-1259] In many situations, with proper and effective medication, a patient with high risk parameters such as blood pressure, cholesterol, may survive for a very long time.

Other than the FRS and European heart score, the fuzzy-evidential based CVD prediction system has been proposed by Khatibi and Montazer in 2010, but they have achieved only 91.58% accuracy.[@b3-ppa-10-1259] Akay proposed the neural network based coronary artery disease prediction system in 1992, achieved an accuracy of 84%, and used the records of 100 patients for testing, but they have only considered the clinical parameters.[@b4-ppa-10-1259] The Bayesian classification and neural network based ischemic heart disease prediction system was proposed by Kukar et al in 1999, but in their study, ECG data were used as input parameter for prediction.[@b5-ppa-10-1259] The probability theory (logistic regression) angiographic coronary disease based system was proposed by Detrano et al in 1989, they collected the data of 425 patients and achieved only 77% accuracy. In their study, only clinical and noninvasive test data were considered as input parameters for their system.[@b6-ppa-10-1259]

In the current study, we have introduced a new machine learning based system which uses the QNN for learning and for its knowledge buildup. On the basis of knowledge gained from data patterns, the proposed system predicts the CVD risk with very high accuracy and is able to update itself with time. Over a period of time, as the data increase, it will update and correct itself on the basis of the current trends and data pattern.

The proposed CVD system has been tested and validated using Indian patients' data and American patients' data, and achieved the highest accuracy among existing systems.

Conclusion
==========

As compared and evaluated during experiments, the proposed CVD prediction system shows the best results on the dataset used, when compared to the FRS. This system has been evaluated and validated with the data of patients and the doctors' diagnoses (predictions). This system will be serving as an aid to medical practitioners in planning better medication strategies. An early diagnosis may be effectively performed by using this system. Data showing prediction accuracy of random testing on different experimental values are shown in [Table 13](#t13-ppa-10-1259){ref-type="table"}. In predicting the risk level, an overall accuracy of 98.57% has been achieved by the proposed system, whereas with the FRS the highest level of accuracy was 19.22%. This system's accuracy is considerably higher compared to other existing approaches. Thus, this system must be used instead of well-known FRS. Hence, the proposed system will serve as a significant tool for doctors/practitioners.
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![Activity diagram of proposed system.\
**Abbreviations:** QNN, quantum neural network; CHD, coronary heart disease; CVD, cardiovascular disease.](ppa-10-1259Fig1){#f1-ppa-10-1259}

![Architecture of quantum neural network.\
**Notes:** *n~i~* denotes the input to the input layer; *O~j~* and *O~k~* denote the output of hidden and output layer, respectively. The weights between input and hidden layers are denoted by *W~ij~* and the weights between hidden and output layers are denoted by *W~kj~*.](ppa-10-1259Fig2){#f2-ppa-10-1259}

![Flowchart of quantum neural network for heart disease prediction system.\
**Notes:** *θ*^r^ denotes quantum interval between sub-states, with the difference of quantum level *r*. *n~s~* denotes the number of grades or excitation levels, *η* is learning rate, *δ~k~* is error rate of output layer, and *δ~j~* error rate of hidden layer. *n~i~* denotes the input to the input layer. *O~j~* and *O~k~* denote the output of hidden and output layer, respectively. The weights between input and hidden layers are denoted by *W~ij~* and the weights between hidden and output layers are denoted by *W~kj~*. t denotes target value.](ppa-10-1259Fig3){#f3-ppa-10-1259}

![Graph showing accuracy of proposed system and Framingham risk score (FRS).\
**Abbreviation:** QNN, quantum neural network.](ppa-10-1259Fig4){#f4-ppa-10-1259}

###### 

Risk levels for total cholesterol

  Total cholesterol                    Risk
  ------------------------------------ ----------------------
  Less than 200 mg/dL (5.17 mmol/L)    Desirable
  200--239 mg/dL (5.17--6.18 mmol/L)   Borderline high risk
  240 and over (6.2 mmol/L)            High risk

###### 

Risk levels for high density lipoprotein

  High density lipoprotein                   Risk
  ------------------------------------------ ---------------------------------------
  Less than 40 mg/dL (men) (1.03 mmol/L)     Increased risk of heart disease
  Less than 50 mg/dL (women) (1.29 mmol/L)   Increased risk of heart disease
  Greater than 60 mg/dL (1.55 mmol/L)        Some protection against heart disease

###### 

Blood pressure range according to age

  Age group   Lower limit[a](#tfn1-ppa-10-1259){ref-type="table-fn"}   Average limit[a](#tfn1-ppa-10-1259){ref-type="table-fn"}   Upper limit[a](#tfn1-ppa-10-1259){ref-type="table-fn"}
  ----------- -------------------------------------------------------- ---------------------------------------------------------- --------------------------------------------------------
  15--19      105/73                                                   117/77                                                     120/81
  20--24      108/75                                                   120/79                                                     132/83
  25--29      109/76                                                   121/80                                                     133/84
  30--34      110/77                                                   122/81                                                     134/85
  35--39      111/78                                                   123/82                                                     135/86
  40--44      112/79                                                   125/83                                                     137/87
  45--49      115/80                                                   127/84                                                     139/88
  50--54      116/81                                                   129/85                                                     142/89
  55--59      118/82                                                   131/86                                                     144/90
  60--64      121/83                                                   134/87                                                     147/91
  65--69      122/84                                                   136/88                                                     149/92
  ≥70         123/85                                                   138/89                                                     151/93

**Note:**

Systolic/diastolic blood pressure range (mmHg).

###### 

BMI range

  Category               BMI range, kg/m^2^
  ---------------------- --------------------
  Severely underweight   \<16.5
  Underweight            16.5 to 18.5
  Normal                 18.5 to 25
  Overweight             25 to 30
  Obese                  \>30

**Abbreviation:** BMI, body mass index.

###### 

Forecast of number of cases (both male and female) of CVD in India

  Year/age group   20--29       30--39       40--49       50--59       60--69       Total
  ---------------- ------------ ------------ ------------ ------------ ------------ ------------
  2000             4,511,192    5,619,470    5,909,011    7,334,040    5,349,313    28,723,024
  2005             6,150,408    7,566,792    7,659,859    10,308,145   6,894,266    38,579,471
  2010             8,317,184    9,608,484    9,682,192    13,981,687   9,137,258    50,726,804
  2015             10,492,011   13,134,021   12,628,644   18,230,363   11,884,240   66,369,279

**Abbreviation:** CVD, cardiovascular disease.

###### 

Input parameters

  Serial number   Parameters
  --------------- --------------------------
  1               Age
  2               Sex
  3               Tobacco smoke
  4               High density lipoprotein
  5               Systolic blood pressure
  6               Total cholesterol
  7               Medication

###### 

Data partition set

  Data partition set   Records   Percentage
  -------------------- --------- ------------
  Training set         189       27.44
  Validation set       250       36.28
  Test set             250       36.28
  Total                689       100.00

###### 

Percentage level of risk categories

  Risk category                  Percentage
  ------------------------------ ------------
  Normal (under baseline risk)   \<26
  Low risk range                 26--51
  Intermediate risk range        51--76
  Highest risk range             ≥76

###### 

Baseline value of parameters

  Serial no   Age   Sex      TC (mg/dL)   SBP (mmHg)   HDL (mg/dL)
  ----------- ----- -------- ------------ ------------ -------------
  1           20    Male     172          120          60
  2           25    Male     174          121          60
  3           30    Male     174          122          60
  4           35    Male     174          123          60
  5           40    Male     174          125          60
  6           45    Male     175          127          60
  7           50    Male     178          129          60
  8           55    Male     182          131          60
  9           60    Male     182          134          60
  10          65    Male     182          136          60
  11          70    Male     182          138          60
  12          20    Female   165          120          70
  13          25    Female   167          121          70
  14          30    Female   167          122          70
  15          40    Female   167          123          70
  16          45    Female   169          125          70
  17          35    Female   172          127          70
  18          50    Female   172          129          70
  19          55    Female   182          131          70
  20          60    Female   182          134          70
  21          65    Female   182          136          70
  22          70    Female   182          138          70

**Abbreviations:** TC, total cholesterol; HDL, high density lipoprotein; SBP, systolic blood pressure.

###### 

Percentage-wise patient distribution for various risk factors

  Risk factors               Percentage-wise patient distribution         
  -------------------------- -------------------------------------- ----- -----
  Blood pressure             8%                                     29%   63%
  Total cholesterol          6%                                     12%   82%
  High density lipoprotein   73%                                    N/A   27%

**Abbreviation:** N/A, not applicable.

###### 

Percentage-wise patient distribution for smoking and being on medication

  Risk factors   Percentage-wise patient distribution   
  -------------- -------------------------------------- --------
  Smoker         24.35%                                 75.65%
  Medication     85.50%                                 14.50%

###### 

Comparison of the results of the proposed algorithm with similar algorithms

  Method                                                        Accuracy
  ------------------------------------------------------------- ----------
  Proposed algorithm with quantum neural network                98.57%
  Fuzzy-evidential based theories[@b3-ppa-10-1259]              91.58%
  Neural network[@b4-ppa-10-1259]                               84%
  Bayesian classification and neural network[@b5-ppa-10-1259]   80%
  Probability theory (logistic regression)[@b6-ppa-10-1259]     77%
  Framingham risk score[@b41-ppa-10-1259]                       19.22%

###### 

Data showing comparison of the proposed system and FRS of random testing on different experimental values

  Parameters used for comparison of proposed system and FRS (patient record)   Manually equated/calculated desired result   Desired result based on doctor's diagnosis   Result and accuracy of proposed QNN based system   \% accuracy QNN   Accuracy group-wise   Result FRS   \% accuracy FRS   Accuracy group-wise                                                                                      
  ---------------------------------------------------------------------------- -------------------------------------------- -------------------------------------------- -------------------------------------------------- ----------------- --------------------- ------------ ----------------- --------------------- ------------------- --------- ------------------- -------- ------- ------- ------- -------
  40                                                                           Male                                         4.20                                         2.20                                               No                117                   Yes          18.75%            Normal                Normal              18.71%    Normal              99.79    99.94   0.99    5.28    19.60
  35                                                                           Female                                       5.00                                         1.81                                               No                121                   Yes          37.50%            Low risk              Low risk            37.50%    Low risk            100.00           0.77    2.04    
  55                                                                           Female                                       5.28                                         1.68                                               No                132                   Yes          43.75%            Low risk              Low risk            43.75%    Low risk            100.00           6.32    14.44   
  45                                                                           Male                                         5.28                                         1.68                                               Yes               126                   Yes          43.75%            Low risk              Low risk            43.70%    Low risk            99.89            9.45    21.60   
  70                                                                           Male                                         5.83                                         1.42                                               No                140                   Yes          56.25%            Intermediate risk     Intermediate risk   56.22%    Intermediate risk   99.95            27.71   49.26   
  65                                                                           Female                                       4.74                                         1.94                                               No                135                   Yes          31.25%            Low risk              Low risk            31.24%    Low risk            99.97            8.34    26.70   
  45                                                                           Male                                         7.17                                         0.78                                               No                190                   Yes          87.50%            Highest risk          Highest risk        87.50%    Highest risk        100.00           15.64   17.87   
  60                                                                           Male                                         5.28                                         1.68                                               No                132                   Yes          43.75%            Low risk              Low risk            43.70%    Low risk            99.89    99.96   13.49   30.83   20.49
  50                                                                           Male                                         6.37                                         1.17                                               Yes               134                   Yes          68.75%            Intermediate risk     Intermediate risk   68.76%    Intermediate risk   100.01           23.37   33.99   
  60                                                                           Female                                       4.20                                         2.20                                               No                130                   Yes          18.75%            Normal                Normal              18.76%    Normal              100.05           4.50    24.00   
  25                                                                           Male                                         6.37                                         1.17                                               Yes               126                   Yes          68.75%            Intermediate risk     Intermediate risk   68.76%    Intermediate risk   100.01           1.68    2.44    
  60                                                                           Male                                         4.20                                         2.20                                               No                126                   Yes          18.75%            Normal                Normal              18.71%    Normal              99.79            7.43    39.60   
  20                                                                           Female                                       7.74                                         0.65                                               No                160                   No           93.75%            Highest risk          Highest risk        93.75%    Highest risk        100.00           0.92    0.99    
  35                                                                           Male                                         6.63                                         1.04                                               Yes               129                   Yes          75.00%            Intermediate risk     Intermediate risk   75.00%    Intermediate risk   100.00           8.67    11.57   
  60                                                                           Male                                         8.29                                         0.52                                               No                190                   Yes          100.00%           Highest risk          Highest risk        100.00%   Highest risk        100.00   99.97   46.52   46.52   30.57
  60                                                                           Female                                       7.74                                         0.65                                               No                180                   Yes          93.75%            Highest risk          Highest risk        93.75%    Highest risk        100.00           31.23   33.32   
  25                                                                           Female                                       8.29                                         0.52                                               No                165                   Yes          100.00%           Highest risk          Highest risk        100.00%   Highest risk        100.00           3.65    3.65    
  25                                                                           Male                                         5.83                                         1.42                                               Yes               123                   Yes          56.25%            Intermediate risk     Intermediate risk   56.22%    Intermediate risk   99.95            1.00    1.79    
  45                                                                           Male                                         5.83                                         1.42                                               No                129                   No           56.25%            Intermediate risk     Intermediate risk   56.22%    Intermediate risk   99.95            6.26    11.13   
  65                                                                           Female                                       7.74                                         0.65                                               No                170                   Yes          93.75%            Highest risk          Highest risk        93.75%    Highest risk        100.00           35.44   37.81   
  70                                                                           Male                                         5.28                                         1.68                                               Yes               136                   Yes          43.75%            Low risk              Low risk            43.70%    Low risk            99.89            34.89   79.74   
  40                                                                           Female                                       4.74                                         1.94                                               No                125                   Yes          31.25%            Low risk              Low risk            31.25%    Low risk            100.00   99.97   1.26    4.04    15.77
  65                                                                           Female                                       6.37                                         1.17                                               No                145                   Yes          68.75%            Intermediate risk     Intermediate risk   68.76%    Intermediate risk   100.01           20.08   29.20   
  45                                                                           Female                                       5.00                                         1.81                                               No                122                   Yes          37.50%            Low risk              Low risk            37.50%    Low risk            100.00           2.16    5.75    
  25                                                                           Male                                         5.28                                         1.68                                               No                120                   Yes          43.75%            Low risk              Low risk            43.70%    Low risk            99.89            0.17    0.39    
  40                                                                           Female                                       6.09                                         1.30                                               No                125                   Yes          62.50%            Intermediate risk     Intermediate risk   62.50%    Intermediate risk   100.00           3.08    4.93    
  40                                                                           Male                                         7.74                                         0.65                                               Yes               160                   No           93.75%            Highest risk          Highest risk        93.73%    Highest risk        99.98            24.33   25.96   
  65                                                                           Male                                         5.28                                         1.68                                               No                134                   Yes          43.75%            Low risk              Low risk            43.70%    Low risk            99.89            17.55   40.10   
  65                                                                           Male                                         3.65                                         2.46                                               Yes               124                   Yes          6.25%             Normal                Normal              6.25%     Normal              100.00   99.90   14.53   23.25   31.00
  55                                                                           Male                                         6.09                                         1.30                                               Yes               134                   Yes          62.50%            Intermediate risk     Intermediate risk   62.50%    Intermediate risk   100.00           26.34   42.15   
  65                                                                           Female                                       5.54                                         1.55                                               No                140                   Yes          50.00%            Low risk              Low risk            49.80%    Low risk            99.60            13.11   26.21   
  55                                                                           Male                                         4.20                                         2.20                                               No                123                   No           18.75%            Normal                Normal              18.71%    Normal              99.79            5.00    26.67   
  55                                                                           Male                                         6.92                                         0.91                                               No                139                   Yes          81.25%            Highest risk          Highest risk        81.26%    Highest risk        100.01           23.89   29.40   
  45                                                                           Male                                         8.29                                         0.52                                               Yes               170                   No           100.00%           Highest risk          Highest risk        100.00%   Highest risk        100.00           38.31   38.31   
  20                                                                           Male                                         8.29                                         0.52                                               No                160                   Yes          100.00%           Highest risk          Highest risk        100.00%   Highest risk        100.00   98.36   1.10    1.10    13.96
  35                                                                           Male                                         8.29                                         0.52                                               Yes               175                   Yes          100.00%           Highest risk          Highest risk        99.96%    Highest risk        99.96            21.32   21.32   
  55                                                                           Female                                       5.83                                         1.42                                               No                135                   Yes          56.25%            Intermediate risk     Intermediate risk   50.75%    Low risk            90.22            8.85    15.74   
  30                                                                           Female                                       4.74                                         1.94                                               No                115                   No           31.25%            Low risk              Low risk            31.25%    Low risk            100.00           0.24    0.78    
  50                                                                           Male                                         7.74                                         0.65                                               Yes               175                   No           93.75%            Highest risk          Highest risk        93.73%    Highest risk        99.98            40.08   42.75   
  35                                                                           Female                                       5.28                                         1.68                                               No                120                   Yes          43.75%            Low risk              Low risk            43.75%    Low risk            100.00           0.91    2.07    
  60                                                                           Female                                       4.45                                         2.07                                               No                130                   Yes          25.00%            Normal                Normal              25.01%    Normal              100.04   99.99   5.17    20.69   17.02
  55                                                                           Female                                       3.91                                         2.33                                               No                125                   Yes          12.50%            Normal                Normal              12.50%    Normal              100.00           2.52    20.14   
  60                                                                           Male                                         6.92                                         0.91                                               Yes               160                   Yes          81.25%            Highest risk          Highest risk        81.26%    Highest risk        100.01           44.34   54.57   
  40                                                                           Male                                         4.74                                         1.94                                               No                120                   Yes          31.25%            Low risk              Low risk            31.21%    Low risk            99.87            1.57    5.02    
  50                                                                           Male                                         4.45                                         2.07                                               No                123                   Yes          25.00%            Normal                Normal              25.00%    Normal              100.00           3.93    15.71   
  35                                                                           Female                                       3.65                                         2.46                                               No                110                   Yes          6.25%             Normal                Normal              6.25%     Normal              100.00           0.17    2.75    
  25                                                                           Female                                       4.20                                         2.20                                               No                110                   Yes          18.75%            Normal                Normal              18.75%    Normal              100.00           0.04    0.24    
  20                                                                           Female                                       4.20                                         2.20                                               No                110                   Yes          18.75%            Normal                Normal              18.75%    Normal              100.00   99.28   0.01    0.06    13.85
  50                                                                           Female                                       4.45                                         2.07                                               No                125                   Yes          25.00%            Normal                Normal              24.01%    Normal              96.04            2.47    9.90    
  40                                                                           Female                                       6.37                                         1.17                                               No                129                   Yes          68.75%            Intermediate risk     Intermediate risk   68.75%    Intermediate risk   100.00           4.10    5.97    
  65                                                                           Male                                         6.92                                         0.91                                               No                175                   No           81.25%            Highest risk          Highest risk        81.26%    Highest risk        100.01           36.06   44.38   
  55                                                                           Male                                         3.91                                         2.33                                               No                121                   Yes          12.50%            Normal                Normal              12.50%    Normal              100.00           4.10    32.78   
  25                                                                           Female                                       6.37                                         1.17                                               No                125                   Yes          68.75%            Intermediate risk     Intermediate risk   68.00%    Intermediate risk   98.91            0.60    0.87    
  40                                                                           Female                                       4.45                                         2.07                                               No                115                   Yes          25.00%            Normal                Normal              25.00%    Normal              100.00           0.75    2.99    
  30                                                                           Female                                       5.83                                         1.42                                               No                120                   Yes          56.25%            Intermediate risk     Intermediate risk   56.25%    Intermediate risk   100.00   99.97   0.71    1.26    14.90
  60                                                                           Male                                         5.54                                         1.55                                               No                134                   Yes          50.00%            Low risk              Low risk            50.00%    Low risk            100.00           15.57   31.14   
  50                                                                           Male                                         6.92                                         0.91                                               Yes               190                   Yes          81.25%            Highest risk          Highest risk        81.26%    Highest risk        100.01           30.24   37.22   
  50                                                                           Female                                       6.63                                         1.04                                               No                180                   Yes          75.00%            Intermediate risk     Intermediate risk   75.00%    Intermediate risk   100.00           11.20   14.94   
  35                                                                           Male                                         4.20                                         2.20                                               No                116                   Yes          18.75%            Normal                Normal              18.71%    Normal              99.79            0.46    2.46    
  55                                                                           Female                                       4.45                                         2.07                                               No                124                   Yes          25.00%            Normal                Normal              25.00%    Normal              100.00           3.36    13.46   
  35                                                                           Female                                       6.63                                         1.04                                               No                160                   Yes          75.00%            Intermediate risk     Intermediate risk   75.00%    Intermediate risk   100.00           2.87    3.82    
  20                                                                           Male                                         5.83                                         1.42                                               Yes               122                   Yes          56.25%            Intermediate risk     Intermediate risk   56.22%    Intermediate risk   99.95    99.98   0.28    0.49    15.05
  55                                                                           Female                                       6.63                                         1.04                                               No                140                   No           75.00%            Intermediate risk     Intermediate risk   75.00%    Intermediate risk   100.00           14.64   19.52   
  70                                                                           Male                                         6.92                                         0.91                                               Yes               180                   Yes          81.25%            Highest risk          Highest risk        81.26%    Highest risk        100.01           56.33   69.33   
  40                                                                           Female                                       5.54                                         1.55                                               No                126                   Yes          50.00%            Low risk              Low risk            50.00%    Low risk            100.00           2.21    4.42    
  45                                                                           Female                                       4.74                                         1.94                                               No                120                   Yes          31.25%            Low risk              Low risk            31.23%    Low risk            99.94            1.72    5.50    
  25                                                                           Female                                       4.74                                         1.94                                               No                115                   Yes          31.25%            Low risk              Low risk            31.25%    Low risk            100.00           0.09    0.30    
  30                                                                           Male                                         3.65                                         2.46                                               Yes               112                   No           6.25%             Normal                Normal              6.25%     Normal              100.00           0.36    5.75    

**Abbreviations:** TC, total cholesterol; HDL, high density lipoprotein; SBP, systolic blood pressure; QNN, quantum neural network; FRS, Framingham risk score.

###### 

Validation based on the dataset from the Framingham study of 5,209 American CVD patients

  Out of 5,209 CVD patients                            Very high risk[a](#tfn7-ppa-10-1259){ref-type="table-fn"}   Intermediate risk[a](#tfn7-ppa-10-1259){ref-type="table-fn"}   Low risk[a](#tfn7-ppa-10-1259){ref-type="table-fn"}   Normal[a](#tfn7-ppa-10-1259){ref-type="table-fn"}
  ---------------------------------------------------- ----------------------------------------------------------- -------------------------------------------------------------- ----------------------------------------------------- ---------------------------------------------------
  Deaths recorded due to myocardial infarction =378    32.93%                                                      41.46%                                                         25.61%                                                Nil
  Deaths recorded due to coronary heart disease =605   37.17%                                                      43.77%                                                         19.06%                                                Nil

**Note:**

Predicted by the proposed system.

**Abbreviation:** CVD, cardiovascular disease.
